Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama.
School of Neuroscience, Virginia Polytechnic and State University, Blacksburg, Virginia.
Glia. 2020 Jul;68(7):1495-1512. doi: 10.1002/glia.23797. Epub 2020 Feb 18.
Kir4.1, a glial-specific inwardly rectifying potassium channel, is implicated in astrocytic maintenance of K homeostasis. Underscoring the role of Kir4.1 in central nervous system (CNS) functioning, genetic mutations in KCNJ10, the gene which encodes Kir4.1, causes seizures, ataxia and developmental disability in humans. Kir4.1 protein and mRNA loss are consistently observed in CNS injury and neurological diseases linked to hyperexcitability and neuronal dysfunction, leading to the notion that Kir4.1 represents an attractive therapeutic target. Despite this, little is understood regarding the mechanisms that underpin this downregulation. Previous work by our lab revealed that DNA hypomethylation of the Kcnj10 gene functions to regulate mRNA levels during astrocyte maturation whereas hypermethylation in vitro led to decreased promoter activity. In the present study, we utilized two vastly different injury models with known acute and chronic loss of Kir4.1 protein and mRNA to evaluate the methylation status of Kcnj10 as a candidate molecular mechanism for reduced transcription and subsequent protein loss. Examining whole hippocampal tissue and isolated astrocytes, in a lithium-pilocarpine model of epilepsy, we consistently identified hypermethylation of CpG island two, which resides in the large intronic region spanning the Kcnj10 gene. Strikingly similar results were observed using the second injury paradigm, a fifth cervical (C5) vertebral hemi-contusion model of spinal cord injury. Our previous work indicates the same gene region is significantly hypomethylated when transcription increases during astrocyte maturation. Our results suggest that DNA methylation can bidirectionally modulate Kcnj10 transcription and may represent a targetable molecular mechanism for the restoring astroglial Kir4.1 expression following CNS insult.
Kir4.1 是一种胶质细胞特异性内向整流钾通道,与星形胶质细胞维持 K 离子平衡有关。KCNJ10 基因编码 Kir4.1,该基因突变与人类癫痫、共济失调和发育障碍有关,这突显了 Kir4.1 在中枢神经系统(CNS)功能中的作用。在 CNS 损伤和与过度兴奋和神经元功能障碍相关的神经疾病中,一致观察到 Kir4.1 蛋白和 mRNA 的丢失,这导致人们认为 Kir4.1 是一个有吸引力的治疗靶点。尽管如此,对于支持这种下调的机制知之甚少。我们实验室之前的工作表明,Kcnj10 基因的 DNA 低甲基化在星形胶质细胞成熟过程中调节 mRNA 水平,而体外的高甲基化导致启动子活性降低。在本研究中,我们利用两种截然不同的损伤模型,已知这两种模型会导致 Kir4.1 蛋白和 mRNA 的急性和慢性丢失,以评估 Kcnj10 的甲基化状态是否为转录减少和随后的蛋白丢失的候选分子机制。在锂-匹罗卡品癫痫模型中,我们检查了整个海马组织和分离的星形胶质细胞,一致发现位于 Kcnj10 基因内含子区域的 CpG 岛 2 发生了高甲基化。使用第二个损伤范例,即第五颈椎(C5)半挫伤脊髓损伤模型,观察到了惊人相似的结果。我们之前的工作表明,当星形胶质细胞成熟时转录增加时,相同的基因区域会显著低甲基化。我们的结果表明,DNA 甲基化可以双向调节 Kcnj10 的转录,并且可能是 CNS 损伤后恢复星形胶质细胞 Kir4.1 表达的靶向分子机制。